Jubilant Life Sciences promoters sell stake worth Rs 455 crore
New Delhi: Two promoters of drug firm Jubilant Life Sciences sold 3 percent stake in the company for over Rs 455 crore, through open market transactions.
The promoters are Jubilant Consumer and Jubilant Advisors LLP.
According to the bulk deal data available with NSE, Jubilant Consumer disposed of 27.36 lakh shares, amounting to 1.72 percent stake in Jubilant Life Sciences.
The shares were offloaded at an average price of Rs 914 per scrip, valuing the transaction at Rs 250.07 crore.
The shares were offloaded at a price of Rs 917.43 apiece, translating into a transaction of Rs 205.32 crore.
Among the buyers of the shares was Copthall Mauritius Investment, which purchased 27.50 lakh shares for Rs 251.35 crore.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd